Incyte Corporation Blog | Talkmarkets

Latest Posts

Top Biotech Bets From The Baker Brothers

Article By: MoneyShow.com

Wednesday, September 28, 2022 5:00 AM EST

Baker Bros. Advisors is a private hedge fund based. Investors that are familiar with biotech companies are likely to find some hidden gems amongst their holdings.

In this article: ACAD, BMRN, BGNE, INCY

Read

Insights On Incyte Corporation

Article By: MoneyShow.com

Saturday, June 4, 2022 6:03 PM EST

In the first quarter of 2022, Incyte Pharmaeuticals reported very strong quarterly results, highlighted by the launch of Opzelura. The launch continues to perform well, with Q1'22 sales of $13 million beating the consensus estimate of $11 million.

In this article: INCY

Read

For Hedge Funds, This Is The Worst 6 Months Since The Financial Crisis: Here's Why

Article By: Tyler Durden

Saturday, August 21, 2021 10:46 PM EST

The core issues behind recent (and continuing) hedge fund under- performance: concentration, crowding and turnover.

In this article: INCY, BRK-B, MA, MCHI, TDG, V, WFC, BIDU, AAPL, AMZN, EXPE, MSFT, BABA, FB, GOOGL, JD, PYPL, WLTW, UAA, SE, BILI, DIDI

Read

3 Promising Oncology Stocks To Consider Adding To Your Portfolio

Article By: StockNews

Monday, June 14, 2021 12:31 AM EST

With tech integration and DNA sequencing increasing the efficacy of potential cancer drugs in the pipeline, we believe biotech names AstraZeneca, Amgen and Incyte are worth adding to a portfolio.

In this article: AZN, INCY, AMGN Also: SPY, CNCR

Read